Editorial: Effect of inhaled corticosteroids on the microbiology of the respiratory tract

Respirology

Volumn 18, Issue 2, 2013, Pages 201-202

  Martin, Matthew ^a   Shaw, Dominick ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

asthma; chronic obstructive pulmonary disease; inhaled corticosteroid; pneumonia

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE;

ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG EFFECT; DRUG MEGADOSE; EDITORIAL; HAEMOPHILUS INFLUENZAE; HOSPITALIZATION; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; KLEBSIELLA PNEUMONIAE; LUNG ALVEOLUS MACROPHAGE; LUNG CLEARANCE; MICROBIAL COMMUNITY; MICROBIOLOGY; MORTALITY; MOUTH FLORA; NONHUMAN; PHAGOCYTOSIS; PHARYNX; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS; QUESTIONNAIRE; RESPIRATORY TRACT MICROBIOLOGY; RISK FACTOR; STREPTOCOCCUS PNEUMONIAE; THRUSH; TREATMENT DURATION; FEMALE; ISOLATION AND PURIFICATION; MALE; NOTE; OROPHARYNX; PNEUMOCOCCAL INFECTION;

ADRENAL CORTEX HORMONES; ASTHMA; FEMALE; HUMANS; MALE; OROPHARYNX; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 84872953812     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12024     Document Type: Editorial

References (10)

1. Singh S, Amin AV, Loke YK,. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: A meta-analysis. Arch. Intern. Med. 2009; 169: 219-229.
2. Andrejak C, Nielsen R, Thomsen VO, et al. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis. Thorax 2012; doi: 10.1136/thoraxjnl-2012-201772.
3. Zhang L, Prietsch SOM, Mendes AP, et al. Inhaled corticosteroids increase the risk of oropharyngeal colonization by Streptococcus pneumoniae in children with asthma. Respirology 2013; 18: 272-277.
4. Cohen HA, Cohen Z, Pomeranz AS, et al. Bacterial contamination of spacer devices used by asthmatic children. J. Asthma 2005; 42: 169-172. (Pubitemid 40776960)
5. Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways. PLoS ONE 2010; 5: e8578.
6. O'Byrne PM, Pedersen S, Carlsson L-G, et al. Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am. J. Respir. Crit. Care Med. 2011; 183: 589-595.
7. Talbot TR, Hartert TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. N. Engl. J. Med. 2005; 352: 2082-2090. (Pubitemid 40667531)
8. Zetterlund A, Linden M, Larsson K,. Effects of beta2-agonists and budesonide on interleukin-1beta and leukotriene B4 secretion: studies of human monocytes and alveolar macrophages. J. Asthma 1998; 35: 565-573. (Pubitemid 28566876)
9. Marshall BG, Wangoo A, Harrison LI, et al. Tumour necrosis factor-alpha production in human alveolar macrophages: modulation by inhaled corticosteroid. Eur. Respir. J. 2000; 15: 764-770. (Pubitemid 30196307)
10. Patterson CM, Morrison RL, D'Souza A, et al. Inhaled fluticasone propionate impairs pulmonary clearance of Klebsiella Pneumoniae in mice. Respir. Res. 2012; 13: 40-48.